Hanson & Doremus Investment Management’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-335
| Closed | -$46K | – | 499 |
|
|
2018
Q2 | $46K | Hold |
335
| – | – | 0.02% | 306 |
|
|
2018
Q1 | $26K | Hold |
335
| – | – | 0.01% | 375 |
|
|
2017
Q4 | $23K | Hold |
335
| – | – | 0.01% | 381 |
|
|
2017
Q3 | $13K | Hold |
335
| – | – | ﹤0.01% | 409 |
|
|
2017
Q2 | $13K | Hold |
335
| – | – | ﹤0.01% | 408 |
|
|
2017
Q1 | $11K | Hold |
335
| – | – | ﹤0.01% | 405 |
|
|
2016
Q4 | $5.93K | Hold |
335
| – | – | ﹤0.01% | 406 |
|
|
2016
Q3 | $8K | Hold |
335
| – | – | ﹤0.01% | 386 |
|
|
2016
Q2 | $6K | Hold |
335
| – | – | ﹤0.01% | 395 |
|
|
2016
Q1 | $6K | Hold |
335
| – | – | ﹤0.01% | 411 |
|
|
2015
Q4 | $7K | Hold |
335
| – | – | ﹤0.01% | 413 |
|
|
2015
Q3 | $6K | Hold |
335
| – | – | ﹤0.01% | 396 |
|
|
2015
Q2 | $11K | Hold |
335
| – | – | ﹤0.01% | 371 |
|
|
2015
Q1 | $16K | Hold |
335
| – | – | 0.01% | 349 |
|
|
2014
Q4 | $7K | Hold |
335
| – | – | ﹤0.01% | 403 |
|
|
2014
Q3 | $6K | Hold |
335
| – | – | ﹤0.01% | 389 |
|
|
2014
Q2 | $9K | Hold |
335
| – | – | ﹤0.01% | 368 |
|
|
2014
Q1 | $11K | Hold |
335
| – | – | 0.01% | 361 |
|
|
2013
Q4 | $8K | Buy |
+335
| New | +$9.37K | ﹤0.01% | 378 |
|
Hanson & Doremus Investment Management's FMI Position: Q3 2018 in Review
Hanson & Doremus Investment Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 335 shares — an estimated $46K sold.
Hanson & Doremus Investment Management first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $46K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Hanson & Doremus Investment Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Hanson & Doremus Investment Management sold 335 Foundation Medicine, Inc. shares in Q3 2018, an estimated $46K.
- Hanson & Doremus Investment Management first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Hanson & Doremus Investment Management's Foundation Medicine, Inc. position peaked at $46K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Hanson & Doremus Investment Management's 13F filing for Q3 2018, filed 24 Oct 2018.